Background. Administrative data are increasingly used to evaluate clinical outcomes and quality of care in pediatric congenital heart surgery (CHS) programs. Several published analyses of large pediatric administrative data sets have relied on the All Patient Refined Diagnosis Related Groups (APR-DRG, version 24) diagnostic classification system. The accuracy of this classification system for patients undergoing CHS is unclear.
Methods. We performed a retrospective cohort study of all 14,098 patients 0 to 5 years of age undergoing any of six selected congenital heart operations, ranging in complexity from isolated closure of a ventricular septal defect to single-ventricle palliation, at 40 tertiary-care pediatric centers in the Pediatric Health Information Systems database between 2007 and 2010. Assigned APRDRGs (cardiac versus noncardiac) were compared using c 2 or Fisher's exact tests between those patients admitted during the first day of life versus later and between those receiving extracorporeal membrane oxygenation support versus those not. Recursive partitioning was used to assess the greatest determinants of APR-DRG type in the model.
Results. Every patient admitted on day 1 of life was assigned to a noncardiac APR-DRG (p < 0.001 for each procedure). Similarly, use of extracorporeal membrane oxygenation was highly associated with misclassification of CHS patients into a noncardiac APR-DRG (p < 0.001 for each procedure). Cases misclassified into a noncardiac APR-DRG experienced a significantly increased mortality (p < 0.001).
Conclusions. In classifying patients undergoing CHS, APR-DRG coding has systematic misclassifications, which may result in inaccurate reporting of CHS case volumes and mortality.
(Ann Thorac Surg 2014;97:641-50) Ó 2014 by The Society of Thoracic Surgeons P ublic reporting of outcome data will soon be mandated of pediatric medicine. The field of congenital heart surgery (CHS) will not be exempt from this expectation and may face significant challenges in providing transparent yet meaningful reporting [1] [2] [3] . Accurate reporting regarding CHS case volumes and outcomes requires accurate classification of cases and appropriate risk adjustment. Previous studies have illustrated problems with case ascertainment in administrative data sets [4] [5] [6] [7] [8] . The All Patient Refined Diagnosis Related Groups (APR-DRG) diagnostic classification system is used in many large pediatric administrative databases, which are often used in clinical research [9] [10] [11] [12] [13] [14] . The APR-DRG system is a classification system developed by a third-party company and widely used by many hospital administrators and reimbursement entities to evaluate the severity of illness and risk of mortality across all patients admitted for inpatient care for the purpose of reimbursement and financial planning. Although there have been some studies evaluating the ability of APR-DRG severity of illness scores to predict mortality [15] [16] [17] , to our knowledge, there have been no studies evaluating the accuracy of the APR-DRG classification system in classifying patients for the purpose of reporting clinical outcomes. In the population undergoing CHS, misclassification of patients into incorrect APR-DRGs may impact the reporting of case volumes and mortality.
We therefore sought to evaluate the accuracy of the APR-DRG (version 24) classification system in patients undergoing CHS. We identified six separate cohorts of patients who underwent CHS during admission on the basis of their diagnoses and procedures. We principally evaluated the assigned APR-DRG for each patient to determine whether they were accurately assigned into cardiac versus noncardiac APR-DRGs. We also performed secondary analyses to determine the effect of hospital case volume on misclassification and to evaluate the impact misclassification had on mortality in the assigned APR-DRG groups.
Patients and Methods

Institutional Review Board Oversight
Our IRB determined that this study of a deidentified data set did not meet the definition of human subjects research (45 CFR 46.102(f)).
Data Source
Data were obtained from the Pediatric Health Information System (PHIS) database, maintained by the Children's Hospital Association (Kansas City, KS). The PHIS database is a large inpatient administrative database containing discharge data from 43 freestanding children's hospitals representing most major metropolitan areas in the United States. A joint effort between participating hospitals, a data manager (Thomson-Reuters, Durham, NC), and the Children's Hospital Association ensures maintenance of data quality and reliability. Three hospitals without detailed clinical services information were excluded from this study.
Study Population
All patients 0 to 5 years of age undergoing isolated closure of a ventricular septal defect (VSD), arterial switch operation for D- 
Exclusion Criteria
Patients were excluded if they were diagnosed with pulmonary hypertension or bronchopulmonary dysplasia, as these patients were likely to have extreme prematurity and extended neonatal intensive care unit admission length, higher rate of tracheostomy, and more likely need for extracorporeal membrane oxygenation (ECMO) support. Inclusion of these patients would potentially have biased our results given that our primary independent variables included being admitted on day of life 1 (DOL1) and receiving ECMO.
Data Collection
Data elements collected from the PHIS database included age at admission, race, sex, payer source, US region, hospital volume, ECMO status, in-hospital mortality, assigned service line (such as cardiac or neonatology), and assigned APR-DRG. The APR-DRGs were classified as cardiac or noncardiac according to an internal classification algorithm (within the PHIS database) assigning patients to specific service lines, including a medical cardiac service line and a surgical cardiac service line. Cardiac APR-DRGs were defined as any APR-DRG within the medical or surgical cardiac service lines.
Variables
The dependent variable was APR-DRG type (cardiac versus noncardiac). The primary independent variables were dichotomous variables defined as whether the patient was admitted on DOL1 versus after and whether the patient received ECMO during the hospitalization or not. An internal data survey performed for qualityimprovement purposes strongly suggested that these variables may be important in determining APR-DRG classification. Other variables included patient sex, payer source, US region, and mortality (categorical variables) as well as hospital case volume and patient age in days (continuous variables). (12) 813 (13) 111 (8) 431 (14) 198 (11) 123 (10) 127 (13) Asian 480 (3) 273 (4) 45 (3) 129 (4) 33 (2) 17 (1) 10(1) American Indian 233 (2) 94 (2) 17 (1) 51 (2) 30 (2) 26 (2) 19 (2) Missing 1,990 (14) 937 (15) 231 (17) 434 (14) 257 (14) 143 (12) 
Statistical Analyses
Population demographics were described using standard summary statistics. Assigned APR-DRGs (cardiac versus noncardiac) were compared using c 2 or Fisher's exact tests. The relationship between both the hospital volume of each cardiac cohort and the mortality rate by hospital were compared with the percent of cases for each cohort that was coded as cardiac APR-DRG using linear regression analysis. Secondary analyses were performed on all six individual cohorts and the overall combined cohort including those patients initially excluded because of a diagnosis of bronchopulmonary dysplasia or pulmonary hypertension. We set the statistical significance for all tests at a probability value of less than 0.05. All of the above analyses were performed using Stata 12.1 (StataCorp, College Station, TX).
To identify factors associated with the patients' final APR-DRG coding status (cardiac or non-cardiac), we used recursive partitioning (employing the Gini coefficient to determine optimal partitions) using Decision Tree in SAS Enterprise Miner 4.3 (SAS Institute Inc, Cary, NC). Predictors included categorical variables (patient sex, payer source, US region, whether the patient was admitted on DOL1, and whether the patient received ECMO) and one continuous variable (patient age in days). All of the analyses described above were performed in each of six individual cohorts, defined by diagnosis and procedure type (VSD, D-TGA, TOF, stage 1, stage 2, Fontan) as well as on the combined cohort containing all six of these individual cohorts.
Results
Study Population
A total of 14,098 admissions from 40 centers (23% Midwest, 19% Northeast, 33% South, 25% West) were included. Combining all six individual cohorts, individual hospital case volumes ranged from 8 to 890 (interquartile range, 290 to 679). The overall mean unadjusted mortality rate for all cohorts was 3.59%, 15.2% (n ¼ 2,150) were admitted on DOL1 and 84.8% (n ¼ 11,948) were admitted after DOL1, and 3.7% (n ¼ 526) received ECMO support during their hospitalization and 96.3% (n ¼ 13,572) did not. Study population characteristics are displayed in Table 1 .
Patient Characteristics and All Patient Refined Diagnosis Related Groups Coding
In each individual cohort evaluated, every patient admitted on DOL1 for the hospitalization during which their surgical repair occurred was classified as noncardiac according to the APR-DRG coding schema used by the PHIS database (Table 2 ). In each individual cohort as well as the group combined as a whole, the association between admission on DOL1 and noncardiac APR-DRG assignment was statistically significant (p < 0.001).
Clinical Characteristics and All Patient Refined Diagnosis Related Groups Coding
In all six individual cohorts, every patient receiving ECMO support during their hospitalization (except 1 patient in the TOF cohort) was classified as noncardiac according to the APR-DRG coding schema (Table 2) . In all six cohorts as well as the group combined as a whole, the association between ECMO support and noncardiac APR-DRG assignment was statistically significant (p < 0.001). As the percent of patients receiving ECMO support increased, the number of patients coded as noncardiac increased.
Hospital Case Volume and All Patient Refined Diagnosis Related Groups Coding
In the overall combined cohort (Fig 1) , as the hospital case volume increased, the percentage of cases coded as cardiac APR-DRG significantly decreased (p < 0.001), with notable variation across the hospitals. The same relationship was observed in the individual cohorts (Fig 2) .
Mortality Rate and All Patient Refined Diagnosis Related Groups Coding
The APR-DRG type (cardiac versus noncardiac) was significantly associated with the individual patient's mortality outcome: cardiac APR-DRG patients had 0.67% mortality, whereas noncardiac APR-DRG patients had 10.61% mortality (p < 0.001). Accordingly, among hospitals as the percentage of patients coded as cardiac APR-DRG decreased, the mean hospital mortality increased significantly (Fig 3; p ¼ 0.017); the circle size in this figure represents the relative hospital volume.
Empirical Algorithm for All Patient Refined Diagnosis Related Groups Classification
We used recursive partitioning to identify factors associated with classifying patients into cardiac versus noncardiac APR-DRGs. When all six groups were combined and analyzed as a single cohort, two factors were highly informative: whether the patient was admitted before or after day of life 7 (using the continuous variable of age in days, the model identified a threshold of 7 days as an important determinant of classification into cardiac or noncardiac APR-DRG), and whether or not the patient received ECMO support, both of which were associated with classification into noncardiac APR-DRGs (Fig 4) . In the D-TGA cohort, the only factor predicting classification into noncardiac APR-DRG was admission age of 7 days or younger (Fig 5A) . In the VSD, TOF, HLHS stage 1, and HLHS stage 2 cohorts, the primary factor predicting a noncardiac APR-DRG classification was admission age of 7 days or younger, followed by receipt of ECMO support (Fig 5) . For the Fontan cohort, the primary predictor for classification as a noncardiac APR-DRG was ECMO support, followed by admission age of less than 131 days (Fig 5B) . In all six cohorts, as well as in the combined group, we found that the mortality was significantly higher in the patients classified as noncardiac APR-DRG as compared with those classified as cardiac.
Cardiac Versus Noncardiac Service Line and All Patient Refined Diagnosis Related Groups Coding
In the overall cohort, nearly 30% of patients were classified into a noncardiac APR-DRG (Table 3) . Within this noncardiac group, a large proportion of patients were assigned APR-DRGs in a neonatology service line. Of note, in the D-TGA and the HLHS stage 1 cohorts, each had greater than 80% of patients classified in a neonatology service line and a greater mortality in the noncardiac as compared with the cardiac APR-DRG patients.
Analysis of the Impact of Exclusion Criteria
To ensure that our exclusion of patients with pulmonary hypertension and bronchopulmonary dysplasia did not bias our results, we performed a secondary analysis including these patients in all six individual cohorts. The results of these repeat analyses were consistent with those of the initial sample, which excluded these patients. With these patients included, the overall sample size increased in each individual cohort, most notably in the VSD and D-TGA cohorts (from 6,281 to 7,201 cases for the VSD cohort and from 1,360 to 1,443 cases for the D-TGA cohort). We again found the following: every patient admitted on DOL1 was assigned to a noncardiac APR-DRG (p < 0.001 for each cohort); the use of ECMO was highly associated with misclassification of CHS patients to a noncardiac APR-DRG (p < 0.001 for each cohort); and the misclassification as a noncardiac APR-DRG was significantly associated with increased mortality (p < 0.001).
Comment
In our study we found that a significant proportion of patients undergoing surgical repair or palliation for a congenital heart defect was classified into noncardiac APR-DRGs. We demonstrated a significant association between assignment of noncardiac APR-DRGs and either admission on DOL1 or the use of ECMO. We found that in nearly every cohort, there was a significant association between greater hospital case volume and a larger percent of cases coded as noncardiac APR-DRGs. One plausible explanation for this might be increased use of ECMO at larger hospitals as well as the increased likelihood for larger hospitals having birthing centers for infants with prenatally diagnosed cardiac disease or having a level III nursery receiving newborn referrals on DOL1 of infants with suspected congenital heart disease. This study provides a novel approach to the evaluation of the accuracy of the APR-DRG classification system in patients undergoing CHS. The analysis was performed in six individual cohorts of patients undergoing different surgical procedures and found consistent results across all individual cohorts and as a combined group.
The APR-DRG risk of mortality and severity of illness categories have been used in research for risk-adjustment purposes when analyzing outcomes. These measures were created, however, for risk-adjustment purposes in the setting of reimbursement, resource allocation, and financial planning. Little is known about the accuracy of these measures when used for risk adjustment in clinical research studies or quality reporting. The risk of mortality and severity of illness categories are assigned within each APR-DRG category and are not comparable across different APR-DRG groups. The fact that many patients undergoing CHS are not classified into cardiac APRDRGs makes using the risk of mortality and severity of illness scores for risk adjustment in clinical research and quality reporting inaccurate.
The problem with misclassification identified in this study may not be limited to the population of patients undergoing CHS. Given that a large proportion of these patients, and often those with the highest mortality, are classified into APR-DRGs in a neonatology service line, this suggests that these inaccuracies may have ripple effects on reporting of outcome data in other clinical realms. In addition, these misclassifications may also lead to inaccurate data provided to hospital administrators for the purpose of determining appropriate resource allocation across service lines.
Limitations
The major limitation of our study is related to the manner of ICD-9-CM coding in regard to congenital heart defects and CHS. Specifically, there is currently no ICD-9-CM code for the Norwood procedure (one approach used for HLHS stage 1 palliation). We were able to address this limitation, however, by using a rigorous search strategy combining both ICD-9-CM diagnosis codes for HLHS and procedure codes for individual components of the operation. More importantly, the results of the analyses in the HLHS stage 1 cohort were similar to those in the other five cohorts. We therefore believe that it is unlikely that this search strategy resulted in any significant selection bias causing the cohort to be systematically different from the other five cohorts.
Conclusions
The APR-DRG coding has important inaccuracies in the classification of patients undergoing CHS. Admission on DOL1 and use of ECMO support are significantly associated with noncardiac APR-DRG assignment. These systematic misclassifications will result in inaccurate reporting of CHS case volumes and outcomes.
Furthermore, in nearly every cohort, as hospital volume increases, the percent of cases coded as cardiac decreases. This may be owing to the influence of increased ECMO use and a larger proportion of inborn or early admissions at larger centers. Additionally, as the percent of cases coded as cardiac APR-DRGs decreases, the mean mortality by hospital increases, demonstrating a statistically significant inverse association between hospital mortality and cardiac APR-DRG status. These data suggest that public reporting of outcomes, particularly for center comparison, using the APR-DRG classification system might lead to flawed conclusions. The nature and implications of these issues warrant further scrutiny, as the effects of APR-DRG misclassification likely reach far beyond the population of patients undergoing CHS. 
